These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9012613)

  • 1. Hypothesis testing and effect size estimation in clinical trials.
    Borenstein M
    Ann Allergy Asthma Immunol; 1997 Jan; 78(1):5-11; quiz 12-6. PubMed ID: 9012613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On design considerations and randomization-based inference for community intervention trials.
    Gail MH; Mark SD; Carroll RJ; Green SB; Pee D
    Stat Med; 1996 Jun; 15(11):1069-92. PubMed ID: 8804140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the statistical power for multiple tests: a case study.
    Yeo A; Qu Y
    Pharm Stat; 2009; 8(1):5-11. PubMed ID: 18381588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect size, confidence interval and statistical significance: a practical guide for biologists.
    Nakagawa S; Cuthill IC
    Biol Rev Camb Philos Soc; 2007 Nov; 82(4):591-605. PubMed ID: 17944619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statistical estimates and clinical trials.
    Braitman LE
    J Biopharm Stat; 1993 Sep; 3(2):249-56. PubMed ID: 8220407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation in flexible two stage designs.
    Brannath W; König F; Bauer P
    Stat Med; 2006 Oct; 25(19):3366-81. PubMed ID: 16220489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redressing the power and effect of significance. A new approach to an old problem: teaching statistics to nursing students.
    Taylor S; Muncer S
    Nurse Educ Today; 2000 Jul; 20(5):358-64. PubMed ID: 10895117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Information-based monitoring of clinical trials.
    Tsiatis AA
    Stat Med; 2006 Oct; 25(19):3236-44; discussion 3320-5, 3326-47. PubMed ID: 16927248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A note on the power of Fisher's least significant difference procedure.
    Meier U
    Pharm Stat; 2006; 5(4):253-63. PubMed ID: 17128424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detecting potential safety issues in clinical trials by Bayesian screening.
    Gould AL
    Biom J; 2008 Oct; 50(5):837-51. PubMed ID: 18932142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis and importance of statistical power and sample size in empirical scientific research].
    Klimek KM
    Wiad Lek; 2008; 61(7-9):211-5. PubMed ID: 19172834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy endpoint selection and multiplicity adjustment methods in clinical trials with inherent multiple endpoint issues.
    Sankoh AJ; D'Agostino RB; Huque MF
    Stat Med; 2003 Oct; 22(20):3133-50. PubMed ID: 14518019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standard versus adaptive monitoring procedures: A commentary.
    Fleming TR
    Stat Med; 2006 Oct; 25(19):3305-12; discussion 3313-4, 3326-47. PubMed ID: 16850447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A note on the use of confidence intervals in psychiatric research.
    Borenstein M
    Psychopharmacol Bull; 1994; 30(2):235-8. PubMed ID: 7831461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stopping clinical trials early for benefit: impact on estimation.
    Freidlin B; Korn EL
    Clin Trials; 2009 Apr; 6(2):119-25. PubMed ID: 19342463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Futility interim monitoring with control of type I and II error probabilities using the interim Z-value or confidence limit.
    Lachin JM
    Clin Trials; 2009 Dec; 6(6):565-73. PubMed ID: 19933716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statistical inference by confidence intervals: issues of interpretation and utilization.
    Sim J; Reid N
    Phys Ther; 1999 Feb; 79(2):186-95. PubMed ID: 10029058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-inferiority trials: the 'at least as good as' criterion.
    Laster LL; Johnson MF
    Stat Med; 2003 Jan; 22(2):187-200. PubMed ID: 12520556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Aspects of sample size determination and power calculation illustrated on examples from rehabilitation research].
    Kutschmann M; Bender R; Grouven U; Berg G
    Rehabilitation (Stuttg); 2006 Dec; 45(6):377-84. PubMed ID: 17123220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Group sequential t-test for clinical trials with small sample sizes across stages.
    Shao J; Feng H
    Contemp Clin Trials; 2007 Sep; 28(5):563-71. PubMed ID: 17434814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.